Radon balneotherapy in rheumatologic diseases: potential mechanisms and implications for cardiovascular autonomic control and inflammation
Abstract
Radon balneotherapy, a form of low-dose radiation treatment, has been utilized for decades in managing rheumatologic diseases, particularly in Central Europe and parts of Asia. Despite ongoing debate about its efficacy, developing research suggests that low-dose exposure to radon may exert anti-inflammatory and analgesic effects, with potential implications for musculoskeletal and cardiovascular health. This narrative review aims to synthesize current knowledge on the biological mechanisms underlying radon therapy, evaluate clinical evidence for its efficacy in rheumatologic conditions, and explore its potential impact on cardiovascular health. Risks, controversies, and regulatory restrictions are also addressed. Preclinical studies indicate that radon therapy modulates oxidative stress responses, immune signalling cascades, and pro-inflammatory cytokine profiles, thereby influencing tissue homeostasis and pain perception. Clinically, benefits have been observed in patients with rheumatoid arthritis, ankylosing spondylitis, and osteoarthritis, particularly with respect to pain alleviation, functional improvement, and quality of life. However, heterogeneity in treatment protocols, study quality, and confounding factors such as the use of heat, carbon dioxide, and/or other concurrent modalities limit generalizability and attributability. Evidence regarding cardiovascular safety remains sparse but suggests that low-dose exposure may have neutral or even protective effects under specific physiological conditions. In summary, radon balneotherapy may have a complementary role alongside other modalities like heat and negative air ions. However, the isolated therapeutic efficacy, long-term safety profile, and cardiovascular implications of radon balneotherapy remain insufficiently characterized. Higher quality multiarmed randomized controlled trials and isolated mechanistic investigations are needed to better delineate its biological mechanisms, optimize protocols, and define its clinical niche.
Related
- Beyond the Bite: Tick Salivary Proteins Targeting Hemostasis and Inflammation; Implications for Cardiovascular Disease
- Exercise-based and mind-body rehabilitation strategies to improve cardiovascular autonomic control in rheumatologic diseases
- Prenatal Inflammation as a Determinant of Long-Term Cardiovascular Risk: Evidence from a Murine Model
- Mimicking in vivo Inflammation: A New in vitro Model of Endothelial Inflammation to Advance the Study of IMID-Associated Cardiovascular Diseases
- Gut microbiota-derived tryptophan metabolites in cardiovascular disease: mechanisms, biomarkers, and precision interventions
BibTeX
@article{rodrigues2026radon,
title = {{Radon balneotherapy in rheumatologic diseases: potential mechanisms and implications for cardiovascular autonomic control and inflammation}},
author = {Gabriel D Rodrigues and Earric Lee and Benoit Dugué and Christian Hanshans and Maria Chiara Maccarone and Konstantinos Triantafyllias and Arnulf Hartl and Eugenijus Kaniusas and Sabrina Mörkl and Thomas E Schmid and Goda-Camille Mickeviciute and Hannes Untner and Werner Klingler and Martin Offenbächer},
journal = {Clinical Rheumatology},
year = {2026},
month = jun,
doi = {10.1007/s10067-026-08202-y},
url = {https://hal.science/hal-05855213v1},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Radon balneotherapy in rheumatologic diseases: potential mechanisms and implications for cardiovascular autonomic control and inflammation
AU - Gabriel D Rodrigues
AU - Earric Lee
AU - Benoit Dugué
AU - Christian Hanshans
AU - Maria Chiara Maccarone
AU - Konstantinos Triantafyllias
AU - Arnulf Hartl
AU - Eugenijus Kaniusas
AU - Sabrina Mörkl
AU - Thomas E Schmid
AU - Goda-Camille Mickeviciute
AU - Hannes Untner
AU - Werner Klingler
AU - Martin Offenbächer
PY - 2026
DA - 2026/06/24
JO - Clinical Rheumatology
DO - 10.1007/s10067-026-08202-y
UR - https://hal.science/hal-05855213v1
AB - Radon balneotherapy, a form of low-dose radiation treatment, has been utilized for decades in managing rheumatologic diseases, particularly in Central Europe and parts of Asia. Despite ongoing debate about its efficacy, developing research suggests that low-dose exposure to radon may exert anti-inflammatory and analgesic effects, with potential implications for musculoskeletal and cardiovascular health. This narrative review aims to synthesize current knowledge on the biological mechanisms underlying radon therapy, evaluate clinical evidence for its efficacy in rheumatologic conditions, and explore its potential impact on cardiovascular health. Risks, controversies, and regulatory restrictions are also addressed. Preclinical studies indicate that radon therapy modulates oxidative stress responses, immune signalling cascades, and pro-inflammatory cytokine profiles, thereby influencing tissue homeostasis and pain perception. Clinically, benefits have been observed in patients with rheumatoid arthritis, ankylosing spondylitis, and osteoarthritis, particularly with respect to pain alleviation, functional improvement, and quality of life. However, heterogeneity in treatment protocols, study quality, and confounding factors such as the use of heat, carbon dioxide, and/or other concurrent modalities limit generalizability and attributability. Evidence regarding cardiovascular safety remains sparse but suggests that low-dose exposure may have neutral or even protective effects under specific physiological conditions. In summary, radon balneotherapy may have a complementary role alongside other modalities like heat and negative air ions. However, the isolated therapeutic efficacy, long-term safety profile, and cardiovascular implications of radon balneotherapy remain insufficiently characterized. Higher quality multiarmed randomized controlled trials and isolated mechanistic investigations are needed to better delineate its biological mechanisms, optimize protocols, and define its clinical niche.
SN - 0770-3198
SN - 1434-9949
ER -